RIVM_Logo_Engels

Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: A pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study)

 

Home / Documents and publications / Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: A pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study)

RIVM Committed to health and sustainability
Menu